DB-310 is a selective immunoproteasome LMP2 inhibitor with an IC50 value of 80.62 nM. DB-310 inhibits the production of IL-1alpha in microglia. DB-310 improves cognitive function in the Tg2576 transgenic mouse model of Alzheimers disease. DB-310 can be used for research related to Alzheimers disease[1].
Molecular Weight:
578.66
CAS Number:
[2338531-17-0]
Formula:
C30H38N6O6
Target:
Interleukin Related,Proteasome
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted